Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study

To estimate risks of major congenital anomaly (MCA) among children of mothers prescribed antidepressants during early pregnancy or diagnosed with depression but without antidepressant prescriptions.

• Publication year

  2014

• Venue

  BJOG: an International Journal of Obstetrics and Gynaecology

• Publication date

  2014-03-11

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/1471-0528.12682PMID 24612301PMCID 4232879
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immigrants Present Improved Obstetric and Neonatal Outcomes Compared to Native Women. A Northern Greek Population Analysis

  2013cited by this paper
• Global and regional estimates of preeclampsia and eclampsia: a systematic review.

  2013cited by this paper
• Methodological Processes in Validating and Analysing the Quality of Population-Based Data: A Case Study Using the Victorian Perinatal Data Collection

  2013cited by this paper
• Use of selective serotonin reuptake inhibitors in pregnancy and cardiac malformations: a propensity‐score matched cohort in CPRD

  2013cited by this paper
• Potential of general practice data for congenital anomaly research: Comparison with registry data in the United Kingdom.

  2013cited by this paper
• Antidepressant Use During Early Pregnancy and the Risk of Congenital Anomalies

  2013cited by this paper
• Revisiting the immigrant paradox in reproductive health: the roles of duration of residence and ethnicity.

  2012cited by this paper
• Maternal ethnicity and pre-eclampsia in New York City, 1995-2003.

  2012cited by this paper
• Serious preeclampsia among different immigrant groups.

  2012cited by this paper
• Pregnancy Outcomes Following Use of Escitalopram: A Prospective Comparative Cohort Study

  2012cited by this paper
• The quality of vital statistics for studying perinatal health: the Spanish case.

  2012cited by this paper
• Secular trends in the epidemiology of pre-eclampsia throughout 40 years in Norway: prevalence, risk factors and perinatal survival.

  2012cited by this paper
• Comparison of intrapartum outcome among immigrant women from Ethiopia and the general obstetric population in Israel

  2012cited by this paper
• Live and Non-Live Pregnancy Outcomes among Women with Depression and Anxiety: A Population-Based Study

  2012cited by this paper
• Exposure to selective serotonin reuptake inhibitors and the risk of congenital malformations: a nationwide cohort study

  2012cited by this paper
• Impact of socioeconomic deprivation on maternal perinatal mental illnesses presenting to UK general practice.

  2012cited by this paper
• Untreated prenatal maternal depression and the potential risks to offspring: a review

  2012cited by this paper
• Antidepressant use during pregnancy: the benefit-risk ratio.

  2012cited by this paper
• Congenital Anomaly Statistics 2010: England and Wales

  2011cited by this paper
• Pre-eclampsia: Risk factors and causal models.

  2011cited by this paper
• Population-based trends in pregnancy hypertension and pre-eclampsia: an international comparative study

  2011cited by this paper
• Causes of death among stillbirths.

  2011cited by this paper
• Dispensing patterns and pregnancy outcomes for women dispensed selective serotonin reuptake inhibitors in pregnancy.

  2011cited by this paper
• Selective Serotonin Reuptake Inhibitors in Human Pregnancy: To Treat or Not to Treat?

  2011cited by this paper
• Recent Immigration and Adverse Pregnancy Outcomes in an Urban Setting in Spain

  2011cited by this paper
• Pregnancy as a major determinant for discontinuation of antidepressants: an analysis of data from The Health Improvement Network.

  2011cited by this paper
• Migration and "Low-Skilled" Workers in Destination Countries

  2011cited by this paper
• Selective Serotonin Reuptake Inhibitors and Risk for Major Congenital Anomalies

  2011cited by this paper
• Glossary: migration and health

  2011cited by this paper
• [Reproductive and perinatal health indicators in immigrant and Spanish-born women in Catalonia and Valencia (2005-2006)].

  2010cited by this paper
• Immigration, work and health in Spain: the influence of legal status and employment contract on reported health indicators

  2010cited by this paper
• Use of selective serotonin-reuptake inhibitors during early pregnancy and risk of congenital malformations: updated analysis

  2010cited by this paper
• Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data

  2010cited by this paper
• Severe maternal morbidity in Canada, 2003 to 2007: surveillance using routine hospitalization data and ICD-10CA codes.

  2010cited by this paper
• Birth Outcomes, Postpartum Health and Primary Care Contacts of Immigrant Mothers in an Australian Nulliparous Pregnancy Cohort Study

  2010cited by this paper
• Validation of spontaneous abortion diagnoses in the Danish National Registry of Patients

  2010cited by this paper
• Immigrants’ duration of residence and adverse birth outcomes: a population-based study

  2010cited by this paper
• Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study

  2009cited by this paper
• Risk of pre-eclampsia in first and subsequent pregnancies: prospective cohort study

  2009cited by this paper
• [Perinatal mortality assessment in native and immigrant women: influence of exhaustiveness and quality of the registries].

  2009cited by this paper
• Incidence of Major Malformations in Infants following Antidepressant Exposure in Pregnancy: Results of a Large Prospective Cohort Study

  2009cited by this paper
• O833 HPV‐16/18 AS04‐adjuvanted cervical cancer vaccine: Correlation between serum and mucosal anti‐HPV‐16 and anti‐HPV‐18 antibody levels

  2009cited by this paper
• Validation of perinatal data in the Discharge Abstract Database of the Canadian Institute for Health Information.

  2009cited by this paper
• Discrimination and mental health in Ecuadorian immigrants in Spain

  2009cited by this paper
• The global impact of pre-eclampsia and eclampsia.

  2009cited by this paper
• First-trimester use of paroxetine and congenital heart defects: a population-based case-control study.

  2009cited by this paper
• Secular trends in the rates of preeclampsia, eclampsia, and gestational hypertension, United States, 1987-2004.

  2008cited by this paper
• Major congenital malformations following prenatal exposure to serotonin reuptake inhibitors and benzodiazepines using population-based health data.

  2008cited by this paper
• Paroxetine and fluoxetine in pregnancy: a prospective, multicentre, controlled, observational study.

  2008cited by this paper
• Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancy.

  2008cited by this paper
• First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects.

  2007cited by this paper
• First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage.

  2007cited by this paper
• Accuracy of birth certificate data by risk factors and outcomes: analysis of data from New Jersey.

  2007cited by this paper
• Increasing use of antidepressants in pregnancy.

  2007cited by this paper
• Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations.

  2007cited by this paper
• Paroxetine in the first trimester and the prevalence of congenital malformations

  2007cited by this paper
• Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research

  2007cited by this paper
• Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy

  2007cited by this paper
• Delivery Outcome in Relation to Maternal Use of Some Recently Introduced Antidepressants

  2007cited by this paper
• Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects.

  2007cited by this paper
• Exposure to mirtazapine during pregnancy: a prospective, comparative study of birth outcomes.

  2006cited by this paper
• The prevalence of stillbirths: a systematic review

  2006cited by this paper
• Maternal Use of Selective Serotonin Reuptake Inhibitors and Risk of Congenital Malformations

  2006cited by this paper
• Antidepressant drugs during pregnancy and infant congenital heart defect.

  2006cited by this paper
• Appropriate assessment of neighborhood effects on individual health: integrating random and fixed effects in multilevel logistic regression.

  2005cited by this paper
• Perinatal depression: prevalence, screening accuracy, and screening outcomes.

  2005cited by this paper
• About the authors

  2004cited by this paper
• Perinatal Risks of Untreated Depression during Pregnancy

  2004cited by this paper
• Social deprivation and poor access to care as risk factors for severe pre-eclampsia.

  2003cited by this paper
• Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy

  2003cited by this paper
• Maternal drug use in early pregnancy and infant cardiovascular defect.

  2003cited by this paper
• Validation of Birth Certificate Data in New York State

  2003cited by this paper
• The confidential enquiry into maternal and child health (CEMACH)

  2003cited by this paper
• Multilevel models for meta-analysis, and their application to absolute risk differences

  2001cited by this paper
• The validity of information on "race" and "Hispanic ethnicity" in California birth certificate data.

  2000cited by this paper
• Health and Deprivation: Inequality and the North

  1987cited by this paper
• American College of Obstetricians and Gynecologists

  1979cited by this paper

• Mental Health Disorders in Pregnancy and the Puerperium: A Comprehensive Review of Guidelines on Screening, Diagnosis, and Management

  2025cites this paper
• Antidepressants in the treatment of depressive disorder during pregnancy: to treat or not to treat?

  2025cites this paper
• Depression and antidepressant use in pregnancy and adverse maternal and offspring outcomes: a systematic review and meta-analysis

  2025cites this paper
• A Study on Retrospective Family Unpredictability, Psychological Symptoms and Psychological Vulnerability

  2024cites this paper
• Prenatal antidepressant use and risk of congenital malformations: A population-based cohort study.

  2024cites this paper
• Safety Profile of Selective Serotonin Reuptake Inhibitors in Real-World Settings: A Pharmacovigilance Study Based on FDA Adverse Event Reporting System

  2024cites this paper
• Meta-analysis of risk factors for congenital heart disease - part 2: maternal medication, reproductive technologies, and familial and fetal factors.

  2024cites this paper
• Fetal cardiac safety of sertraline use during pregnancy

  2023cites this paper
• Environmental and parental risk factors for congenital solitary functioning kidney — a case–control study

  2023cites this paper
• Maternal exposure to SSRIs or SNRIs and the risk of congenital abnormalities in offspring: A systematic review and meta-analysis

  2023cites this paper
• Prevalence of Selective Serotonin Reuptake Inhibitor Use Among Pregnant Women From 2017 to 2020 in King Abdulaziz Medical City, Jeddah, Saudi Arabia: A Retrospective Study

  2023cites this paper
• Peripartum Depression: Detection and Treatment.

  2023cites this paper
• Consensus Panel Recommendations for the Pharmacological Management of Pregnant Women with Depressive Disorders

  2023influential citation
• Impact of Prenatal Health Conditions and Health Behaviors in Pregnant Women on Infant Birth Defects in the United States Using CDC-PRAMS 2018 Survey

  2023cites this paper
• Maternal Stressful Life Events During the Periconceptional Period and Orofacial Clefts: A Systematic Review and Meta-Analysis

  2022cites this paper
• Major congenital malformations in offspring of women with chronic diseases—impact of the disease or the treatment?

  2022cites this paper
• Fetal Congenital Cardiac and Vascular Disorders Associated with Sertraline Treatment during Pregnancy: Analysis of FAERS Data

  2022cites this paper
• The role of prenatal exposure to antidepressants, anxiolytic, and hypnotics and its underlying illness on the risk of miscarriage using BIFAP database

  2022cites this paper
• Maternal, Fetal, and Child Outcomes of Mental Health Treatments in Women: A Meta‐Analysis of Pharmacotherapy

  2021cites this paper
• Maternal psychological distress, education, household income, and congenital heart defects: a prospective cohort study from the Japan environment and children’s study

  2021cites this paper
• The identification and validity of congenital malformation diagnoses in UK electronic health records: A systematic review

  2021cites this paper
• Environmental Exposures and Congenital Heart Disease.

  2021cites this paper
• Depression and Antidepressants During Pregnancy: Craniofacial Defects Due to Stem/Progenitor Cell Deregulation Mediated by Serotonin

  2021cites this paper
• A systematic review and meta-analysis considering the SSRI, SNRI and TCA classes of antidepressants and the risk for congenital heart defects

  2020cites this paper
• The importance of depression during pregnancy

  2020cites this paper
• Risk factors for congenital heart disease: The Baby Hearts Study, a population-based case-control study

  2020cites this paper
• Antidepressant prescriptions for prenatal and postpartum women in Japan: A health administrative database study.

  2020cites this paper
• Antenatal depression and offspring health outcomes

  2020cites this paper
• Versorgung und Versorgungssystem

  2020cites this paper
• A Systematic Review and Meta-Analysis Considering the Risk for Congenital Heart Defects of Antidepressant Classes and Individual Antidepressants

  2020cites this paper
• Pregnancy outcome following in-utero exposure to ondansetron: a prospective comparative observational study.

  2020cites this paper
• Association between antidepressant use during pregnancy and congenital anomalies in children: A retrospective cohort study based on Japanese claims data

  2020influential citation
• In utero exposure to antidepressant medication and neonatal and child outcomes: a systematic review

  2020influential citation
• Depression in pregnancy

  2019cites this paper
• Epidemiology of the Use of Psychotropic Drugs in Pregnant and Nursing Women

  2019cites this paper
• Maternal Use of Antidepressants and Infant Congenital Malformations

  2019cites this paper
• Antidepressants in Pregnancy

  2019cites this paper
• A Matched Case-Control Study on the Association Between Colds, Depressive Symptoms during Pregnancy and Congenital Heart Disease in Northwestern China

  2019cites this paper
• Preexisting illness, fetal malformation, and seizure control rates in pregnant women with epilepsy.

  2019cites this paper
• General Principles of Psychopharmacology

  2018cites this paper
• Selective serotonin reuptake inhibitor use in pregnant women; pharmacogenetics, drug-drug interactions and adverse effects

  2018cites this paper
• Effect of maternal fluoxetine exposure on lung, heart, and kidney development in rat neonates

  2018cites this paper
• In-utero exposure to metformin for type 2 diabetes or polycystic ovary syndrome: A prospective comparative observational study.

  2018cites this paper
• Selective serotonin reuptake inhibitor use during early pregnancy and congenital malformations: a systematic review and meta-analysis of cohort studies of more than 9 million births

  2018cites this paper
• Selective Serotonin Reuptake Inhibitor Use in Pregnancy: Repercussions on the Oblivious Passenger

  2018cites this paper
• Psychotropic medication use during pregnancy

  2018cites this paper
• Use of Psychotropic Medications Among Pregnant Women with Bipolar Disorder: Patterns, Determinants, and Impact on Perinatal Outcomes

  2018cites this paper
• Characteristics and consequences of antenatal exposure to selective serotonin reuptake inhibitors

  2018cites this paper
• Fluoxetine and congenital malformations: a systematic review and meta‐analysis of cohort studies

  2017cites this paper
• Depression in Pregnancy.

  2017cites this paper
• Pharmacotherapy of mood disorders and psychosis in pre- and post-natal women

  2017cites this paper
• Effect of antidepressants use in pregnancy on foetus development and adverse effects in newborns.

  2017cites this paper
• What are the risks associated with different Selective Serotonin Re-uptake Inhibitors (SSRIs) to treat depression and anxiety in pregnancy? An evaluation of current evidence.

  2017influential citation
• Psychotropic drugs in pregnancy - do they reduce or increase the risks for the fetus? Part One: antidepressants, antipsychotics

  2017cites this paper
• Use of selective serotonin-reuptake inhibitors in the first trimester and risk of cardiovascular-related malformations: a meta-analysis of cohort studies

  2017cites this paper
• Peripartum depression: Early recognition improves outcomes

  2017cites this paper
• Selective serotonin reuptake inhibitor antidepressant use in first trimester pregnancy and risk of specific congenital anomalies: a European register-based study inhibitor antidepressant in a

  2017influential citation
• Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec Pregnancy Cohort

  2017influential citation
• Maternal and infant genetic variants, maternal periconceptional use of selective serotonin reuptake inhibitors, and risk of congenital heart defects in offspring: population based study

  2017cites this paper
• Sertraline use in the first trimester and risk of congenital anomalies: a systemic review and meta‐analysis of cohort studies

  2017cites this paper
• Antidepressants, Antipsychotics, and Mood Stabilizers in Pregnancy: What Do We Know and How Should We Treat Pregnant Women with Depression

  2017cites this paper
• Selective Serotonin Reuptake Inhibitors during Pregnancy: Do We Have Now More Definite Answers Related to Prenatal Exposure?

  2017cites this paper
• Gastrointestinal Diseases During Pregnancy

  2017cites this paper
• Praxis der Pharmakotherapie der Depression in Schwangerschaft und Stillzeit

  2017cites this paper
• Depression and Anxiety During Pregnancy: Evaluating the Literature in Support of Clinical Risk-Benefit Decision-Making

  2016cites this paper
• Teratogenic Potential of Commonly Prescribed Psychotropic Drugs

  2016cites this paper
• Safety of Selective Serotonin Reuptake Inhibitors in Pregnancy: A Review of Current Evidence

  2016influential citation
• Polycystic Ovary Syndrome, Obesity, and Pregnancy

  2016cites this paper
• Use of Selective Serotonin Reuptake Inhibitors During Pregnancy and Risk of Congenital Cardiac Malformations

  2016cites this paper
• Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants in Pregnancy and Congenital Anomalies: Analysis of Linked Databases in Wales, Norway and Funen, Denmark

  2016cites this paper
• Selective serotonin reuptake inhibitors and congenital heart anomalies: comparative cohort studies of women treated before and during pregnancy and their children.

  2016cites this paper
• A Swedish Population-based Study of Adverse Birth Outcomes among Pregnant Women Treated with Buprenorphine or Methadone: Preliminary Findings

  2016cites this paper
• Psychopharmacotherapy in Pregnancy and Breastfeeding

  2016cites this paper
• Links between serotonin reuptake inhibition during pregnancy and neurodevelopmental delay/spectrum disorders: A systematic review of epidemiological and physiological evidence

  2016cites this paper
• Primary Care Screening for and Treatment of Depression in Pregnant and Postpartum Women: Evidence Report and Systematic Review for the US Preventive Services Task Force.

  2016cites this paper
• The Risk of Congenital Heart Anomalies Following Prenatal Exposure to Serotonin Reuptake Inhibitors—Is Pharmacogenetics the Key?

  2016cites this paper
• Maternal health behaviours: the development and feasibility evaluation of a mindfulness-based behaviour change intervention for pregnant women

  2016cites this paper
• Meta‐analysis requires independent observations and freedom from bias

  2016cites this paper
• The risk of major cardiac malformations associated with paroxetine use during the first trimester of pregnancy: a systematic review and meta-analysis.

  2016cites this paper
• How to take into account exposure to drugs over time in pharmacoepidemiology studies of pregnant women?

  2016cites this paper
• Selective Serotonin Reuptake Inhibitors (SSRIs) and the Risk of Congenital Heart Defects: A Meta-Analysis of Prospective Cohort Studies

  2015cites this paper
• Are antidepressants safe in the first trimester of pregnancy?

  2015cites this paper
• Implications of Polycystic Ovary Syndrome for Pregnancy and for the Health of Offspring

  2015cites this paper
• Perinatal mental health: What every neonatologist should know.

  2015cites this paper
• Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design

  2015cites this paper
• Women's perception of risks of adverse fetal pregnancy outcomes: a large-scale multinational survey

  2015cites this paper
• Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design

  2015cites this paper
• Treatment of Special Groups: Children, Pregnant, Elderly, and Mentally Disabled

  2015cites this paper
• Special Issues for Pregnant Women with Mental Illness

  2015cites this paper
• Selective serotonin reuptake inhibitor antidepressant use in first trimester pregnancy and risk of specific congenital anomalies: a European register-based study

  2015cites this paper
• Case–control studies require appropriate population controls: an example of error in the SSRI birth defect literature

  2015cites this paper
• Depression during Pregnancy.

  2015cites this paper
• Early pregnancy exposure to selective serotonin reuptake inhibitors, risks of major structural malformations, and hypothesized teratogenic mechanisms

  2015influential citation
• Anästhesie und Schmerztherapie während der Schwangerschaft

  2015cites this paper
• An obstetrician's guide to perinatal psychiatry

  2014cites this paper